N4 Pharma Plc (LON:N4P – Get Free Report) dropped 7.7% on Tuesday . The company traded as low as GBX 0.55 ($0.01) and last traded at GBX 0.60 ($0.01). Approximately 432,387 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 1,201,942 shares. The stock had previously closed at GBX 0.65 ($0.01).
N4 Pharma Stock Performance
The company has a market capitalization of £2.57 million, a PE ratio of -55.00 and a beta of -0.37. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The business’s fifty day moving average is GBX 0.64 and its two-hundred day moving average is GBX 0.58.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than N4 Pharma
- What is Insider Trading? What You Can Learn from Insider Trading
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Most Volatile Stocks, What Investors Need to Know
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Invest in Biotech Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
